Research ExplorerPublicationsCompositions and Methods for Boosting the Efficacy of Adopti...

Compositions and Methods for Boosting the Efficacy of Adoptive Cellular Immunotherapy.

Standard

Compositions and Methods for Boosting the Efficacy of Adoptive Cellular Immunotherapy. / Berger, Fred; Riddell, Stanley R.

Patent No.: WO 2016/069647 Al.

Research output: Patent

Harvard

Berger, F & Riddell, SR, Compositions and Methods for Boosting the Efficacy of Adoptive Cellular Immunotherapy., Patent No. WO 2016/069647 Al.

APA

Berger, F., & Riddell, S. R. (2014). Compositions and Methods for Boosting the Efficacy of Adoptive Cellular Immunotherapy. (Patent No. WO 2016/069647 Al).

Vancouver

Berger F, Riddell SR. Compositions and Methods for Boosting the Efficacy of Adoptive Cellular Immunotherapy. WO 2016/069647 Al. 2014.

Bibtex

@misc{5760d0a497574ab9817c8a1eb638c6fd,
title = "Compositions and Methods for Boosting the Efficacy of Adoptive Cellular Immunotherapy.",
abstract = "Abstract: The present disclosure provides compositions and methods for boosting, augmenting or enhancing the efficacy of the adoptive cellular immunotherapy by using modified T cells expressing an antigen binding protein in conjunction with modified cells (such as hematopoietic progenitor cells, modified human immune system cells or a combination thereof) expressing the antigen spe - cifically bound by the antigen binding protein of the modified T cells.",
author = "Fred Berger and Riddell, {Stanley R}",
year = "2014",
language = "English",
type = "Patent",
note = "WO 2016/069647 Al; A61K 39/00",

}

RIS

TY - PAT

T1 - Compositions and Methods for Boosting the Efficacy of Adoptive Cellular Immunotherapy.

AU - Berger, Fred

AU - Riddell, Stanley R

PY - 2014

Y1 - 2014

N2 - Abstract: The present disclosure provides compositions and methods for boosting, augmenting or enhancing the efficacy of the adoptive cellular immunotherapy by using modified T cells expressing an antigen binding protein in conjunction with modified cells (such as hematopoietic progenitor cells, modified human immune system cells or a combination thereof) expressing the antigen spe - cifically bound by the antigen binding protein of the modified T cells.

AB - Abstract: The present disclosure provides compositions and methods for boosting, augmenting or enhancing the efficacy of the adoptive cellular immunotherapy by using modified T cells expressing an antigen binding protein in conjunction with modified cells (such as hematopoietic progenitor cells, modified human immune system cells or a combination thereof) expressing the antigen spe - cifically bound by the antigen binding protein of the modified T cells.

M3 - Patent

M1 - WO 2016/069647 Al

Y2 - 2014/10/27

ER -